Bill Doyle is the executive chairman of Novocure, an oncology company developing a novel cancer treatment using a proprietary therapy called TTFields, which uses electric fields to disrupt solid tumor cancer cell division. He is also executive chairman of Blink Health, a digital savings platform tackling the high cost of prescription medications. Previously, Bill servedRead more..
Posts Tagged ‘Bill Doyle’
William (Bill) Doyle is the executive chairman of Novocure, a commercial-stage oncology company which is currently developing Tumor Treating Fields, a new therapy for solid tumor cancers. He is also a managing partner of venture capital investor WFD Ventures LLC. Previously, Bill served as an executive at Johnson & Johnson, where he served on theRead more..